1. Home
  2. SKYW vs LQDA Comparison

SKYW vs LQDA Comparison

Compare SKYW & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWest Inc.

SKYW

SkyWest Inc.

HOLD

Current Price

$96.86

Market Cap

3.6B

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$40.13

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYW
LQDA
Founded
1972
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
SKYW
LQDA
Price
$96.86
$40.13
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$123.67
$41.00
AVG Volume (30 Days)
315.5K
947.1K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
33.20
51.81
EPS
10.35
N/A
Revenue
$2,971,963,000.00
$158,320,000.00
Revenue This Year
$8.35
$278.87
Revenue Next Year
$3.55
$57.13
P/E Ratio
$9.37
N/A
Revenue Growth
N/A
1031.18
52 Week Low
$82.14
$11.85
52 Week High
$123.94
$46.67

Technical Indicators

Market Signals
Indicator
SKYW
LQDA
Relative Strength Index (RSI) 56.43 61.28
Support Level $94.62 $31.75
Resistance Level $103.04 $46.67
Average True Range (ATR) 3.19 1.84
MACD 0.97 0.29
Stochastic Oscillator 68.54 89.80

Price Performance

Historical Comparison
SKYW
LQDA

About SKYW SkyWest Inc.

SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. SkyWest generally provides regional flights and utilizes smaller, lower-cost aircraft to carry passengers who book tickets through partner airlines. It partners with carriers to fly and operate aircraft for a fee and may use the carriers' brands and ground support to coordinate marketing and transport passengers. The company has two reportable segments: SkyWest Airlines and SWC, which generate maximum revenue, and SkyWest Leasing activities.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: